Organoseleno cytostatic derivatives: Autophagic cell death with AMPK and JNK activation

Eur J Med Chem. 2019 Aug 1:175:234-246. doi: 10.1016/j.ejmech.2019.04.074. Epub 2019 May 4.

Abstract

Selenocyanates and diselenides are potential antitumor agents. Here we report two series of selenium derivatives related to selenocyanates and diselenides containing carboxylic, amide and imide moieties. These compounds were screened for their potency and selectivity against seven tumor cell lines and two non-malignant cell lines. Results showed that MCF-7 cells were especially sensitive to the treatment, with seven compounds presenting GI50 values below 10 μM. Notably, the carboxylic selenocyanate 8b and the cyclic imide 10a also displayed high selectivity for tumor cells. Treatment of MCF-7 cells with these compounds resulted in cell cycle arrest at S phase, increased levels of pJNK and pAMPK and caspase independent cell death. Autophagy inhibitors wortmannin and chloroquine partially prevented 8b and 10a induced cell death. Consistent with autophagy, increased Beclin1 and LC3-IIB and reduced SQSTM1/p62 levels were detected. Our results point to 8b and 10a as autophagic cell death inducers.

Keywords: Autophagy; Cancer; Cyclic imide; Diselenide; Selenocyanate.

MeSH terms

  • Adenylate Kinase / metabolism*
  • Autophagy / drug effects*
  • Cell Cycle Checkpoints / drug effects
  • Cell Death / drug effects*
  • Cell Line, Tumor
  • Cytostatic Agents / administration & dosage
  • Cytostatic Agents / chemistry
  • Cytostatic Agents / pharmacology*
  • Dose-Response Relationship, Drug
  • Enzyme Activation
  • Humans
  • MAP Kinase Kinase 4 / metabolism*
  • Organoselenium Compounds / administration & dosage
  • Organoselenium Compounds / chemistry
  • Organoselenium Compounds / pharmacology*
  • S Phase / drug effects

Substances

  • Cytostatic Agents
  • Organoselenium Compounds
  • MAP Kinase Kinase 4
  • Adenylate Kinase